The initiation of bone remodeling depends in part on the support of osteoclast differentiation by stromal cells that appear to be of the osteoblast lineage. The key mechanism by which these stromal/osteoblastic cells support osteoclastogenesis is expression of RANKL (receptor activator of NFkappaB ligand). Hormones that stimulate osteoclast formation, such as PTH, do so by stimulating RANKL expression in stromal/osteoblastic cells but not other cell types. However, strikingly little is known about how this is accomplished. The long-term goal of this project is to identify the mechanisms that control RANKL expression in stromal/osteoblastic cells. Preliminary studies have determined that PTH stimulates RANKL transcription via a PKA-CREB pathway and that PTH also stimulates RANKL mRNA stability. Promoter-reporter constructs containing up to 7 kb of RANKL 5'-flanking region are regulated weakly or not at all by osteoclastogenic agents, suggesting that regulation of this gene involves distant regulatory elements. Consistent with this, a 160-kb DNA fragment harboring the murine RANKL gene as well as extensive flanking regions contains sequences sufficient for appropriate regulation by PKA in stably transfected stromal/osteoblastic cells.
In Aim 1, cis-acting elements required for transcriptional control of RANKL expression by PTH will be identified by deletion analysis of the 160 kb DNA fragment and DNase I hypersensitivity assays. Elements will be further localized by DNase I protection and gel shift assays. Site-directed mutagenesis of the full-length construct will confirm the significance of each site.
In Aim 2, cis-acting sequences that mediate post-transcriptional control of RANKL mRNA by PTH will be identified. Tagged murine RANKL mRNA will be conditionally expressed in stromal/osteoblastic cells and sequences involved in destabilization/PTH-induced stabilization will be mapped by deletion analysis.
Aim 3 will identify regions of the RANKL gene involved in tissue-specific expression. This will be accomplished by creating transgenic mice harboring luciferase reporter constructs containing different portions of the RANKL gene and flanking region. Information gained from these studies will lead to a better understanding of the cellular factors involved in the support of osteoclast formation and thereby identify novel targets for anti-resorptive therapy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR049794-03
Application #
6917112
Study Section
Oral Biology and Medicine Subcommittee 1 (OBM)
Program Officer
Sharrock, William J
Project Start
2003-09-29
Project End
2008-06-30
Budget Start
2005-07-01
Budget End
2006-06-30
Support Year
3
Fiscal Year
2005
Total Cost
$275,480
Indirect Cost
Name
University of Arkansas for Medical Sciences
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
122452563
City
Little Rock
State
AR
Country
United States
Zip Code
72205
O'Brien, Charles A; Morello, Roy (2018) Modeling Rare Bone Diseases in Animals. Curr Osteoporos Rep 16:458-465
Xiong, Jinhu; Almeida, Maria; O'Brien, Charles A (2018) The YAP/TAZ transcriptional co-activators have opposing effects at different stages of osteoblast differentiation. Bone 112:1-9
Xiong, Jinhu; Cawley, Keisha; Piemontese, Marilina et al. (2018) Soluble RANKL contributes to osteoclast formation in adult mice but not ovariectomy-induced bone loss. Nat Commun 9:2909
Almeida, Maria; Laurent, Michaƫl R; Dubois, Vanessa et al. (2017) Estrogens and Androgens in Skeletal Physiology and Pathophysiology. Physiol Rev 97:135-187
Piemontese, Marilina; Almeida, Maria; Robling, Alexander G et al. (2017) Old age causes de novo intracortical bone remodeling and porosity in mice. JCI Insight 2:
Piemontese, Marilina; Xiong, Jinhu; Fujiwara, Yuko et al. (2016) Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice. Am J Physiol Endocrinol Metab 311:E587-93
Fujiwara, Yuko; Piemontese, Marilina; Liu, Yu et al. (2016) RANKL (Receptor Activator of NF?B Ligand) Produced by Osteocytes Is Required for the Increase in B Cells and Bone Loss Caused by Estrogen Deficiency in Mice. J Biol Chem 291:24838-24850
Piemontese, Marilina; Onal, Melda; Xiong, Jinhu et al. (2016) Low bone mass and changes in the osteocyte network in mice lacking autophagy in the osteoblast lineage. Sci Rep 6:24262
Xiong, Jinhu; Piemontese, Marilina; Onal, Melda et al. (2015) Osteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling Bone. PLoS One 10:e0138189
Piemontese, Marilina; Onal, Melda; Xiong, Jinhu et al. (2015) Suppression of autophagy in osteocytes does not modify the adverse effects of glucocorticoids on cortical bone. Bone 75:18-26

Showing the most recent 10 out of 38 publications